News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Zelos Therapeutics to Present at Two Investor Conferences
October 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Dr. Brian MacDonald, Chief Executive Officer of Zelos Therapeutics, Inc., will present at the following two investor conferences:
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst
Diabetes
ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval
June 9, 2026
·
2 min read
·
Tristan Manalac
Obesity
ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold
June 8, 2026
·
5 min read
·
Heather McKenzie
Obesity
ADA: Boehringer leans on fat mass benefits as obesity bet delivers ‘less competitive’ weight reduction
June 8, 2026
·
2 min read
·
Tristan Manalac
